---
figid: PMC10521544__12935_2023_3046_Fig7_HTML
pmcid: PMC10521544
image_filename: 12935_2023_3046_Fig7_HTML.jpg
figure_link: /pmc/articles/PMC10521544/figure/Fig6/
number: Fig. 6
figure_title: ''
caption: The integrated pathways map of luteolin in OS setting. (A) The PI3K-AKT signaling
  pathway. (B) The IL17 signaling pathway. (C) The TNF signaling pathway. The common
  targets of luteolin and OS were marked in pink and core targets were marked in red
article_title: Network pharmacology and experimental verification-based strategy for
  exploring the mechanisms of luteolin in the treatment of osteosarcoma.
citation: Renxuan Huang, et al. Cancer Cell Int. 2023;23:213.
year: '2023'

doi: 10.1186/s12935-023-03046-x
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central

keywords:
- Luteolin
- Network pharmacology
- Osteosarcoma
- Molecular docking
- scRNA-seq
- Orthotopic mouse model

---
